Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden: An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative.

IF 2.7 3区医学 Q2 DERMATOLOGY

Dermatology Pub Date : 2025-07-07 DOI:10.1159/000539706

Anja Pahlow Mose, Karin Arvidsson, Karin Nyberg, Dorra Bouazzi, Robin Christensen, Gregor B E Jemec, Victoria Marmgren

{"title":"Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden: An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative.","authors":"Anja Pahlow Mose, Karin Arvidsson, Karin Nyberg, Dorra Bouazzi, Robin Christensen, Gregor B E Jemec, Victoria Marmgren","doi":"10.1159/000539706","DOIUrl":null,"url":null,"abstract":"Introduction: Epidemiologic studies of hidradenitis suppurativa (HS) from Sweden are limited. The aim of this study was to investigate the prevalence of HS in Lund and Gothenburg, Sweden.Methods: This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. The study was multicentered and included apparently healthy adults accompanying a patient to the Department of either Endocrinology or Ophthalmology in a Swedish University Hospital from February 1 to November 30, 2023. Recruitment occurred in the waiting rooms where the study participants were consecutively invited to answer a validated screening questionnaire which had been translated into Swedish. In the questionnaire, the key screening questions asked were whether the study participant had had 2 or more boils/abscesses in the past 6 months and if these were in any of the typical skin sites for HS. Screen-positive and randomly selected screen-negative participants were clinically examined for HS by a dermatologist to verify the results.Results: A total of 551 accompanying adults were approached of which 505 answered the questionnaire. The prevalence of HS in this sample was 0.99% (95% confidence interval [0.43%-2.30%]). There was a statistically significant difference in BMI between the HS and control group, but not in relation to age or sex.Conclusion: HS appears to be a common chronic disease in Sweden. Also, there is a strong association between overweight/obesity and HS.","PeriodicalId":11185,"journal":{"name":"Dermatology","volume":" ","pages":"1-5"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233967/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000539706","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Epidemiologic studies of hidradenitis suppurativa (HS) from Sweden are limited. The aim of this study was to investigate the prevalence of HS in Lund and Gothenburg, Sweden.

Methods: This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative. The study was multicentered and included apparently healthy adults accompanying a patient to the Department of either Endocrinology or Ophthalmology in a Swedish University Hospital from February 1 to November 30, 2023. Recruitment occurred in the waiting rooms where the study participants were consecutively invited to answer a validated screening questionnaire which had been translated into Swedish. In the questionnaire, the key screening questions asked were whether the study participant had had 2 or more boils/abscesses in the past 6 months and if these were in any of the typical skin sites for HS. Screen-positive and randomly selected screen-negative participants were clinically examined for HS by a dermatologist to verify the results.

Results: A total of 551 accompanying adults were approached of which 505 answered the questionnaire. The prevalence of HS in this sample was 0.99% (95% confidence interval [0.43%-2.30%]). There was a statistically significant difference in BMI between the HS and control group, but not in relation to age or sex.

Conclusion: HS appears to be a common chronic disease in Sweden. Also, there is a strong association between overweight/obesity and HS.

查看原文本刊更多论文

瑞典隆德和哥德堡的化脓性汗腺炎患病率：来自全球化脓性汗腺炎地图集倡议的分析。

瑞典化脓性汗腺炎（HS）流行病学研究有限。本研究的目的是调查瑞典隆德和哥德堡的HS患病率。方法：本研究是全球化脓性汗腺炎地图集（GHiSA）计划的一部分。该研究是多中心的，包括在2023年2月1日至11月30日期间陪同患者到瑞典大学医院内分泌科或眼科就诊的明显健康的成年人。招募在候诊室进行，研究参与者被连续邀请回答一份被翻译成瑞典语的有效筛选问卷。在问卷调查中，关键的筛选问题是研究参与者在过去6个月内是否有2个或更多的疖子/脓肿，以及这些脓疮是否在任何典型的HS皮肤部位。筛查阳性和随机选择筛查阴性的参与者由皮肤科医生临床检查HS以验证结果。结果：共接触陪同成人551人，其中505人回答了问卷。本组HS患病率为0.99%（95%可信区间[0.43% ~ 2.30%]）。HS组与对照组的BMI差异有统计学意义，但与年龄和性别无关。结论：HS在瑞典是一种常见的慢性疾病。此外，超重/肥胖与HS之间有很强的联系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dermatology 医学-皮肤病学

CiteScore

6.40

自引率

2.90%

发文量

审稿时长

1 months

期刊介绍： Published since 1893, ''Dermatology'' provides a worldwide survey of clinical and investigative dermatology. Original papers report clinical and laboratory findings. In order to inform readers of the implications of recent research, editorials and reviews prepared by invited, internationally recognized scientists are regularly featured. In addition to original papers, the journal publishes rapid communications, short communications, and letters to ''Dermatology''. ''Dermatology'' answers the complete information needs of practitioners concerned with progress in research related to skin, clinical dermatology and therapy. The journal enjoys a high scientific reputation with a continually increasing impact factor and an equally high circulation.